|
US8252742B2
(en)
*
|
2004-12-30 |
2012-08-28 |
Hill's Pet Nutrition, Inc. |
Methods for enhancing the quality of life of a senior animal
|
|
JP5337479B2
(ja)
|
2005-05-04 |
2013-11-06 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
新規化合物
|
|
KR20130101596A
(ko)
*
|
2005-07-08 |
2013-09-13 |
마텍 바이오싸이언스스 코포레이션 |
치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산
|
|
WO2008063772A2
(en)
*
|
2006-10-13 |
2008-05-29 |
The Brigham And Women's Hospital Inc. |
Resolvin d series and protectin d1 mitigate acute kidney injury
|
|
MX2009004337A
(es)
*
|
2006-11-01 |
2009-05-22 |
Pronova Biopharma Norge As |
Compuestos lipidos omega-3.
|
|
US8399516B2
(en)
|
2006-11-01 |
2013-03-19 |
Pronova Biopharma Norge As |
Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR)
|
|
US8816110B2
(en)
|
2007-02-15 |
2014-08-26 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
|
|
CA2672513C
(en)
|
2007-02-15 |
2010-05-25 |
Centre De Recherche Sur Les Biotechnologies Marines |
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
|
|
WO2008113177A1
(en)
|
2007-03-20 |
2008-09-25 |
Centre De Recherche Sur Les Biotechnologies Marines |
Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
|
|
KR20100100818A
(ko)
*
|
2007-10-31 |
2010-09-15 |
프로노바 바이오파마 노르지 에이에스 |
새로운 ｄｈａ 유도체 및 약물로서 그들의 사용
|
|
WO2009061208A1
(en)
|
2007-11-09 |
2009-05-14 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
WO2009134147A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Pronova Biopharma Norge As |
Lipid compositions containing derivatives of epa and dha an their use thereof
|
|
WO2009149496A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Central Northern Adelaide Health Service |
Treatment of diabetes and complications thereof and related disorders
|
|
EP2147910A1
(en)
*
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
ES2345241B1
(es)
|
2009-03-16 |
2011-09-08 |
Lipopharma Therapeutics |
Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
|
|
CN107233337A
(zh)
|
2009-04-29 |
2017-10-10 |
阿马里纳药物爱尔兰有限公司 |
含有epa和心血管剂的药物组合物以及使用其的方法
|
|
KR101783817B1
(ko)
|
2009-05-08 |
2017-10-23 |
프로노바 바이오파마 너지 에이에스 |
심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산
|
|
EP2248798A1
(en)
|
2009-05-08 |
2010-11-10 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
BRPI1011883A2
(pt)
|
2009-06-15 |
2016-09-13 |
Amarin Pharma Inc |
uso de composições para redução de triglicerídeos sem elevar os níveis de o ldl-c em um paciente sob o tratamento concomitante com estatina
|
|
WO2011149766A2
(en)
*
|
2010-05-23 |
2011-12-01 |
Jingxuan Kang |
Lipid-tailored pharmaceutical agents
|
|
SG10201509127YA
(en)
|
2010-11-05 |
2015-12-30 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
NZ744990A
(en)
|
2010-11-29 |
2019-10-25 |
Amarin Pharmaceuticals Ie Ltd |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
US8715648B2
(en)
|
2011-02-16 |
2014-05-06 |
Pivotal Therapeutics Inc. |
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
|
|
US9119826B2
(en)
|
2011-02-16 |
2015-09-01 |
Pivotal Therapeutics, Inc. |
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
|
|
US8952000B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
|
|
US8951514B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
|
|
JP2014505730A
(ja)
*
|
2011-02-16 |
2014-03-06 |
ピヴォタル セラピューティクス インコーポレイテッド |
心血管疾患患者（ＣＶＤ）および糖尿病患者における体重を減らすための、ω３脂肪酸および抗肥満剤を含む製剤
|
|
CN107050457A
(zh)
|
2012-01-06 |
2017-08-18 |
翁特拉制药公司 |
游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
|
|
EP2844303B1
(en)
|
2012-05-03 |
2021-09-15 |
Beth Israel Deaconess Medical Center, Inc. |
Lipids that increase insulin sensitivity and methods of using the same
|
|
KR20150028233A
(ko)
|
2012-05-07 |
2015-03-13 |
옴테라 파마슈티칼스, 인크. |
스타틴 및 오메가-３ 지방산의 조성물
|
|
WO2013192109A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
|
US9629820B2
(en)
|
2012-12-24 |
2017-04-25 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
|
CA2894709C
(en)
*
|
2012-12-24 |
2022-08-09 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (epa) formulations
|
|
US10123986B2
(en)
|
2012-12-24 |
2018-11-13 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
|
US11351139B2
(en)
|
2013-02-28 |
2022-06-07 |
Basf As |
Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
|
US10604473B2
(en)
*
|
2013-03-15 |
2020-03-31 |
Beth Israel Deaconess Medical Center, Inc. |
Lipids that increase insulin sensitivity and methods of using the same
|
|
JP5870952B2
(ja)
*
|
2013-03-25 |
2016-03-01 |
富士ゼロックス株式会社 |
データ処理装置およびプログラム
|
|
US9447020B2
(en)
|
2013-10-31 |
2016-09-20 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
|
|
WO2015171516A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
WO2015195662A1
(en)
|
2014-06-16 |
2015-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
|
|
US9242008B2
(en)
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
CN107074884A
(zh)
|
2014-06-18 |
2017-08-18 |
西蒂斯制药有限责任公司 |
活性剂的矿物质氨基酸复合物
|
|
AU2016256552B2
(en)
|
2015-04-28 |
2021-04-01 |
Pronova Biopharma Norge As |
Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
|
|
GB201521085D0
(en)
*
|
2015-11-30 |
2016-01-13 |
Biozep As |
Use
|
|
KR102437682B1
(ko)
|
2016-06-03 |
2022-08-29 |
테티스 파마수티컬스 엘엘씨 |
특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
|
|
WO2017214527A1
(en)
|
2016-06-10 |
2017-12-14 |
Beth Israel Deaconess Medical Center, Inc. |
Fatty acid esters of hydroxy fatty acids (fahfas) for use in the treatment of type 1 diabetes
|
|
MX391168B
(es)
|
2017-07-07 |
2025-03-21 |
The Us Secretary Department Of Health & Human Services |
Derivados de acido graso y su uso.
|
|
AU2018354090B2
(en)
*
|
2017-10-23 |
2024-10-24 |
Epitracker, Inc. |
Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|
|
WO2019153073A1
(en)
|
2018-02-07 |
2019-08-15 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
|
|
US11166933B2
(en)
|
2018-05-03 |
2021-11-09 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
|
|
EP3796976A4
(en)
|
2018-05-23 |
2022-03-30 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO LONGEVITY AND QUALITY OF AGING
|
|
MA50490A
(fr)
|
2018-09-24 |
2020-09-02 |
Amarin Pharmaceuticals Ie Ltd |
Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
|
|
EP3877336A1
(en)
*
|
2018-11-05 |
2021-09-15 |
Pacific Industrial Development Corporation |
Method of making aei-type zeolites having a high silica to alumina molar ratio (sar)
|
|
EP3908374A4
(en)
|
2019-01-09 |
2022-12-28 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
JP7404382B2
(ja)
|
2019-03-04 |
2023-12-25 |
エピトラッカー インコーポレイテッド |
脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
|
|
US12226390B2
(en)
|
2019-07-21 |
2025-02-18 |
Scf Pharma Inc. |
Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
|
|
CA3160676A1
(en)
|
2019-11-12 |
2021-05-20 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter
|
|
CN111233694B
(zh)
*
|
2020-03-05 |
2021-05-11 |
浙江大学 |
具有降血脂作用的线性聚酮类化合物及其制备方法和应用
|
|
US11986452B2
(en)
|
2021-04-21 |
2024-05-21 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of heart failure
|
|
JP2024539823A
(ja)
|
2021-11-03 |
2024-10-31 |
エピトラッカー インコーポレイテッド |
老化の質および寿命に関係する状態の治療のためのペンタデカノイルカルニチン
|
|
CN119019255A
(zh)
*
|
2024-08-16 |
2024-11-26 |
合肥工业大学 |
一种dha分子活性探针及其制备方法和应用
|